Resignation of V Santhanakrishnan, as Company Secretary and Compliance Officer with effect from 13th June 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech informed the BSE that V Santhanakrishnan has resigned as Company Secretary and Compliance Officer with effect from June 13, 2025, citing pursuit of other opportunities. His resignation letter was originally submitted on April 25, 2025, seeking relief by June 10. The Board also approved audited standalone financial results for the quarter and year ended March 31, 2025. Revenue from operations fell sharply to Rs 3,776.91 lakhs in FY25 from Rs 6,232.34 lakhs in FY24. Profit before tax dropped to Rs 64.63 lakhs from Rs 300.91 lakhs, though profit after tax remained nearly flat at Rs 144.63 lakhs (vs Rs 145.74 lakhs) due to a deferred tax credit. EPS stood at Rs 0.32 versus Rs 0.37 in the previous year. The meeting was adjourned to June 13 for consolidated results.
The resignation of the Company Secretary is a key managerial personnel change that shareholders should monitor for any governance or compliance implications. The sharp revenue contraction and steep fall in pre-tax profit raise concerns about operational performance, though the bottom-line was preserved by a one-time deferred tax adjustment.